These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. Bohnen NI; Albin RL; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Frey KA JAMA Neurol; 2015 Feb; 72(2):194-200. PubMed ID: 25506674 [TBL] [Abstract][Full Text] [Related]
25. Amyloid Burden and Depressive Symptom Trajectories in Older Adults at Risk of Developing Cognitive Decline. Conejero I; Dubois J; Gutierrez LA; Delrieu J; Arbus C; Garcia M; Lopez-Castroman J; Courtet P; Gabelle A J Clin Psychiatry; 2021 Aug; 82(5):. PubMed ID: 34352166 [No Abstract] [Full Text] [Related]
26. Apathy in patients with Parkinson disease without dementia or depression: a PET study. Robert G; Le Jeune F; Lozachmeur C; Drapier S; Dondaine T; Péron J; Travers D; Sauleau P; Millet B; Vérin M; Drapier D Neurology; 2012 Sep; 79(11):1155-60. PubMed ID: 22895582 [TBL] [Abstract][Full Text] [Related]
27. Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease. Ye BS; Jeon S; Yoon S; Kang SW; Baik K; Lee Y; Chung SJ; Oh JS; Moon H; Kim JS; Lee PH; Sohn YH J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):197-204. PubMed ID: 28951497 [TBL] [Abstract][Full Text] [Related]
28. Apathy in patients with Parkinson disease as a function of side of onset. Harris E; McNamara P; Durso R J Geriatr Psychiatry Neurol; 2013 Jun; 26(2):95-104. PubMed ID: 23584852 [TBL] [Abstract][Full Text] [Related]
29. Progression from unilateral to bilateral parkinsonism in early Parkinson disease: implication of mesocortical dopamine dysfunction by PET. Yagi S; Yoshikawa E; Futatsubashi M; Yokokura M; Yoshihara Y; Torizuka T; Ouchi Y J Nucl Med; 2010 Aug; 51(8):1250-7. PubMed ID: 20660377 [TBL] [Abstract][Full Text] [Related]
31. Apathy in Mild Parkinson's Disease: Neuropsychological and Neuroimaging Evidence. Alzahrani H; Antonini A; Venneri A J Parkinsons Dis; 2016 Oct; 6(4):821-832. PubMed ID: 27567885 [TBL] [Abstract][Full Text] [Related]
32. Neuroanatomical correlates of apathy in Parkinson's disease: A magnetic resonance imaging study using voxel-based morphometry. Reijnders JS; Scholtissen B; Weber WE; Aalten P; Verhey FR; Leentjens AF Mov Disord; 2010 Oct; 25(14):2318-25. PubMed ID: 20669264 [TBL] [Abstract][Full Text] [Related]
33. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833 [TBL] [Abstract][Full Text] [Related]
34. Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease. Petrou M; Davatzikos C; Hsieh M; Foerster BR; Albin RL; Kotagal V; Müller ML; Koeppe RA; Herman WH; Frey KA; Bohnen NI Acad Radiol; 2016 May; 23(5):577-81. PubMed ID: 26874576 [TBL] [Abstract][Full Text] [Related]
35. Dopaminergic Depletion, β-Amyloid Burden, and Cognition in Lewy Body Disease. Yoo HS; Lee S; Chung SJ; Lee YH; Lee PH; Sohn YH; Lee S; Yun M; Ye BS Ann Neurol; 2020 May; 87(5):739-750. PubMed ID: 32078179 [TBL] [Abstract][Full Text] [Related]
36. Apathy and impaired emotional facial recognition networks overlap in Parkinson's disease: a PET study with conjunction analyses. Robert G; Le Jeune F; Dondaine T; Drapier S; Péron J; Lozachmeur C; Sauleau P; Houvenaghel JF; Travers D; Millet B; Vérin M; Drapier D J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1153-8. PubMed ID: 24403280 [TBL] [Abstract][Full Text] [Related]
37. Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study. Sousa M; Moreira F; Jesus-Ribeiro J; Marques I; Cunha F; Canário N; Freire A; Januário C Eur Neurol; 2018; 79(1-2):13-20. PubMed ID: 29131091 [TBL] [Abstract][Full Text] [Related]
38. Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates. Chou KL; Lenhart A; Koeppe RA; Bohnen NI Parkinsonism Relat Disord; 2014 Oct; 20(10):1076-80. PubMed ID: 25085750 [TBL] [Abstract][Full Text] [Related]
39. Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease. Masala C; Solla P; Liscia A; Defazio G; Saba L; Cannas A; Cavazzana A; Hummel T; Haehner A J Neurol; 2018 Aug; 265(8):1764-1771. PubMed ID: 29804147 [TBL] [Abstract][Full Text] [Related]
40. Characteristics of apathy in treatment-naïve patients with Parkinson's disease. Terashi H; Ueta Y; Kato H; Mitoma H; Aizawa H Int J Neurosci; 2019 Jan; 129(1):16-21. PubMed ID: 30035696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]